Podlesak Dennis — SEC insider filings
SEC reporting owner CIK 1314595. 11 insider filings on record with FilingPulse; latest filed 2026-10-30.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2021-02-05 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 13,967 shares, $197,077 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 3 filings — 144,415 shares, $2,886,803 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 66,840 shares @ $24.20 ($1,617,381) in Syndax Pharmaceuticals Inc, filed 2022-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc (SNDX) | Director | 11 | 1 leg · 13,967 sh · $197,077 | 7 legs · 144,415 sh · $2,886,803 | 22 |
Insider filings — Podlesak Dennis
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Option exercise (M): 8,000 @ $11.81 · Sale (S): 8,000 @ $14.21 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 48,000 @ $0 | EDGAR |
| 2025-08-18 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Option exercise (M): 19,200 @ $7.20 · Sale (S): 19,200 @ $14.19 · Option exercise (M): 19,200 @ $7.20 · Sale (S): 19,200 @ $15.54 · Option exercise (M): 19,200 @ $7.20 · Sale (S): 19,200 @ $15.84 · +4 more | EDGAR |
| 2025-02-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-02-09 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2023-02-03 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 32,000 @ $0 | EDGAR |
| 2022-09-16 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Option exercise (M): 66,840 @ $6.32 · Sale (S): 66,840 @ $24.20 · Option exercise (M): 5,419 @ $6.32 · Sale (S): 5,419 @ $23.43 · Option exercise (M): 6,556 @ $6.35 · Sale (S): 6,556 @ $23.43 · +3 more | EDGAR |
| 2022-02-03 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 32,000 @ $0 | EDGAR |
| 2021-10-06 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Other (J): 463 @ $0 | EDGAR |
| 2021-04-22 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Purchase (P): 13,967 @ $14.11 | EDGAR |
| 2021-02-05 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 29,333 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1314595 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs